US Stock MarketDetailed Quotes

Summit Therapeutics (SMMT)

Watchlist
  • 18.790
  • -0.160-0.84%
Close May 13 15:59 ET
  • 18.570
  • -0.220-1.17%
Pre 04:00 ET
14.58BMarket Cap-11.82P/E (TTM)

Summit Therapeutics (SMMT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
192.01%195.21M
418.72%1.09B
242.80%224.88M
301.20%234.21M
1,174.24%568.44M
57.71%66.85M
137.76%210.98M
81.17%65.6M
184.88%58.38M
182.45%44.61M
Selling and administrative expenses
301.60%62.59M
824.75%556.7M
445.67%77.58M
399.25%103.12M
2,509.44%360.42M
35.34%15.59M
105.71%60.2M
34.46%14.22M
280.09%20.65M
118.68%13.81M
-General and administrative expense
301.60%62.59M
824.75%556.7M
445.67%77.58M
399.25%103.12M
2,509.44%360.42M
35.34%15.59M
105.71%60.2M
34.46%14.22M
280.09%20.65M
118.68%13.81M
Research and development costs
158.69%132.62M
256.60%537.67M
186.66%147.29M
247.51%131.1M
575.44%208.02M
66.05%51.27M
153.53%150.78M
107.07%51.38M
146.19%37.72M
225.87%30.8M
Other taxes
----
----
----
----
----
----
66.91%-313K
-15.17%-205K
199.62%264K
-507.69%-159K
Operating profit
-192.01%-195.21M
-418.72%-1.09B
-242.80%-224.88M
-301.20%-234.21M
-1,174.24%-568.44M
-57.71%-66.85M
-137.76%-210.98M
-81.17%-65.6M
-184.88%-58.38M
-182.45%-44.61M
Net non-operating interest income expense
0
0
0
0
0
47.23%-8.69M
99.69%-9K
9.85%-2.45M
-23.34%-3.1M
Non-operating interest income
----
----
----
----
----
----
29.44%13.47M
----
----
----
Non-operating interest expense
----
--0
--0
--0
--0
--0
-47.23%8.69M
-99.69%9K
-9.85%2.45M
23.34%3.1M
Other net income (expense)
46.98%5.79M
1,005.86%14.84M
30.16%5.75M
-47.18%2.42M
121.53%2.73M
93.32%3.94M
99.68%-1.64M
74.02%4.42M
135.25%4.58M
-452.81%-12.67M
Gain on sale of security
46.98%5.79M
11.38%14.89M
30.16%5.75M
-47.18%2.42M
19.19%2.78M
93.32%3.94M
16.91%13.37M
67.17%4.42M
127.76%4.58M
-35.11%2.33M
Special income (charges)
----
--0
--0
--0
--0
----
97.12%-15.01M
--0
--0
---15.01M
-Less:Impairment of capital assets
----
----
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
----
----
----
----
----
-97.12%15.01M
--0
----
--15.01M
Other non- operating income (expenses)
----
---53K
--0
----
---53K
----
----
----
----
----
Income before tax
-201.09%-189.42M
-387.81%-1.08B
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
64.01%-221.3M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
Income tax
Net income
-201.09%-189.42M
-387.81%-1.08B
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
64.01%-221.3M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
Net income continuous Operations
-201.09%-189.42M
-387.81%-1.08B
-258.11%-219.12M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
64.01%-221.3M
-67.33%-61.19M
-164.50%-56.25M
-310.31%-60.39M
Minority interest income
Net income attributable to the parent company
-201.09%-189.42M
-387.81%-1.08B
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
64.01%-221.32M
-67.37%-61.2M
-164.50%-56.25M
-310.31%-60.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-201.09%-189.42M
-387.81%-1.08B
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
64.01%-221.32M
-67.37%-61.2M
-164.50%-56.25M
-310.31%-60.39M
Basic earnings per share
-166.67%-0.24
-364.52%-1.44
-222.22%-0.29
-287.50%-0.31
-744.44%-0.76
-50.00%-0.09
68.69%-0.31
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
Diluted earnings per share
-171.42%-0.2443
-364.52%-1.44
-222.22%-0.29
-287.50%-0.31
-744.44%-0.76
-50.00%-0.09
68.69%-0.31
-800.00%-0.09
-166.67%-0.08
-350.00%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 192.01%195.21M418.72%1.09B242.80%224.88M301.20%234.21M1,174.24%568.44M57.71%66.85M137.76%210.98M81.17%65.6M184.88%58.38M182.45%44.61M
Selling and administrative expenses 301.60%62.59M824.75%556.7M445.67%77.58M399.25%103.12M2,509.44%360.42M35.34%15.59M105.71%60.2M34.46%14.22M280.09%20.65M118.68%13.81M
-General and administrative expense 301.60%62.59M824.75%556.7M445.67%77.58M399.25%103.12M2,509.44%360.42M35.34%15.59M105.71%60.2M34.46%14.22M280.09%20.65M118.68%13.81M
Research and development costs 158.69%132.62M256.60%537.67M186.66%147.29M247.51%131.1M575.44%208.02M66.05%51.27M153.53%150.78M107.07%51.38M146.19%37.72M225.87%30.8M
Other taxes ------------------------66.91%-313K-15.17%-205K199.62%264K-507.69%-159K
Operating profit -192.01%-195.21M-418.72%-1.09B-242.80%-224.88M-301.20%-234.21M-1,174.24%-568.44M-57.71%-66.85M-137.76%-210.98M-81.17%-65.6M-184.88%-58.38M-182.45%-44.61M
Net non-operating interest income expense 0000047.23%-8.69M99.69%-9K9.85%-2.45M-23.34%-3.1M
Non-operating interest income ------------------------29.44%13.47M------------
Non-operating interest expense ------0--0--0--0--0-47.23%8.69M-99.69%9K-9.85%2.45M23.34%3.1M
Other net income (expense) 46.98%5.79M1,005.86%14.84M30.16%5.75M-47.18%2.42M121.53%2.73M93.32%3.94M99.68%-1.64M74.02%4.42M135.25%4.58M-452.81%-12.67M
Gain on sale of security 46.98%5.79M11.38%14.89M30.16%5.75M-47.18%2.42M19.19%2.78M93.32%3.94M16.91%13.37M67.17%4.42M127.76%4.58M-35.11%2.33M
Special income (charges) ------0--0--0--0----97.12%-15.01M--0--0---15.01M
-Less:Impairment of capital assets --------------------------0------------
-Less:Other special charges -------------------------97.12%15.01M--0------15.01M
Other non- operating income (expenses) -------53K--0-------53K--------------------
Income before tax -201.09%-189.42M-387.81%-1.08B-258.11%-219.12M-312.05%-231.79M-836.84%-565.71M-44.72%-62.91M64.01%-221.3M-67.33%-61.19M-164.50%-56.25M-310.31%-60.39M
Income tax
Net income -201.09%-189.42M-387.81%-1.08B-258.11%-219.12M-312.05%-231.79M-836.84%-565.71M-44.72%-62.91M64.01%-221.3M-67.33%-61.19M-164.50%-56.25M-310.31%-60.39M
Net income continuous Operations -201.09%-189.42M-387.81%-1.08B-258.11%-219.12M-312.05%-231.79M-836.84%-565.71M-44.72%-62.91M64.01%-221.3M-67.33%-61.19M-164.50%-56.25M-310.31%-60.39M
Minority interest income
Net income attributable to the parent company -201.09%-189.42M-387.81%-1.08B-258.11%-219.17M-312.05%-231.79M-836.84%-565.71M-44.72%-62.91M64.01%-221.32M-67.37%-61.2M-164.50%-56.25M-310.31%-60.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -201.09%-189.42M-387.81%-1.08B-258.11%-219.17M-312.05%-231.79M-836.84%-565.71M-44.72%-62.91M64.01%-221.32M-67.37%-61.2M-164.50%-56.25M-310.31%-60.39M
Basic earnings per share -166.67%-0.24-364.52%-1.44-222.22%-0.29-287.50%-0.31-744.44%-0.76-50.00%-0.0968.69%-0.31-800.00%-0.09-166.67%-0.08-350.00%-0.09
Diluted earnings per share -171.42%-0.2443-364.52%-1.44-222.22%-0.29-287.50%-0.31-744.44%-0.76-50.00%-0.0968.69%-0.31-800.00%-0.09-166.67%-0.08-350.00%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More